Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents-Reference-Cited by-同舟云学术

Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents

Published:2021-04-07 Issue:11 Volume:73 Page:2145-2147
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Van Praet Jens T¹²^ORCID,Vandecasteele Stefaan¹,De Roo Anneleen³,De Vriese An S¹²^ORCID,Reynders Marijke⁴

Affiliation:

1. Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium

2. Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

3. Curando, Ruiselede, Belgium

4. Department of Laboratory Medicine, Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab300/39584976/ciab300.pdf

Reference4 articles.

1. Impressive boosting of anti-S1/S2 IgG production in COVID-19–experienced patients after the first shot of the BNT162b2 mRNA COVID-19 vaccine;Capetti;Clin Infect Dis,2021

2. Editorial: COVID19 vaccination in frail people: lots of hope and some questions;Rolland;J Nutr Health Aging,2021

3. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates;Poland;Lancet,2020

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study;Health Science Reports;2023-09

2. Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination;Clinical Immunology;2023-06

3. COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment;Vaccines;2023-03-03

4. Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination;Clinical and Experimental Immunology;2023-02-21

5. Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy;Human Vaccines & Immunotherapeutics;2023-01-02